![]() Escalier Biosciences Escalier Biosciences is a biopharmaceutical company developing small molecule therapeutics RORγt for psoriasis and other autoimmune disorders treatment. | ![]() Veloxis Pharmaceuticals Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies. | ![]() AOBiome AOBiome is a pioneer in bacterial therapy.
We represent a new approach to skin health that focuses on the restoring good bacteria to your biome | ![]() Rallybio Rallybio is a clinical-stage biotechnology company developing drugs with the main focus on antibodies, small molecules, and engineered proteins. | |
Founding Date | Founding Date N/A | Founding Date 2002 | Founding Date 2013 | Founding Date 2018 |
Type | Type Private | Type Subsidiary | Type Private | Type Public |
Tags | ||||
Locations | Locations Nijmegen, NL HQ Encinitas, US | Locations København, DK HQ Cary, US Cary, US | Locations Cambridge, US HQ | Locations New Haven, US HQ Farmington, US |
Employees | Employees N/A | Employees 54 | Employees 16 | Employees 28 |
Financial | ||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) kr39.5m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) $858k (FY, 2025) |
Net income | Net income N/A | Net income (kr5.3m) (FY, 2018) | Net income N/A | Net income ($9m) (FY, 2025) |
Funding | ||||
Latest funding round | Latest funding round $ 19m (over 8 years ago) | Latest funding round N/A | Latest funding round $ 30m (over 9 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 19m | Total funding raised $ 60m | Total funding raised $ 38.7m | Total funding raised $ 182m |

Veloxis Pharmaceuticals is a biopharmaceutical company that identifies, develops, and commercializes products used in transplantation and adjacent therapies.
View company
AOBiome is a pioneer in bacterial therapy. We represent a new approach to skin health that focuses on the restoring good bacteria to your biome
View company
Rallybio is a clinical-stage biotechnology company developing drugs with the main focus on antibodies, small molecules, and engineered proteins.
View company